By Date
Overton wins best poster at MicroTAS
Evan Miller receives Mathers Foundation grant
Evan Miller, Professor of Biochemistry, Biophysics and Structural Biology, was named a Spring 2026 Mathers Foundation Grantee. In collaboration with Hillel Adesnik and Stephen Brohawn, they are developing a high-throughput screening method using long-wavelength voltage-sensitive fluorophores to rapidly discover engineered opsin variants with enhanced properties.
In parallel mouse studies, researchers fail to replicate many reported effects of psilocybin
Neuroscientists from the lab of Assistant Professor of Cell Biology, Development and Physiology Andrea Gomez, alongside other collaborators from Berkeley, UCSF and Stanford ran parallel trials of psilocybin to see what behavioral effects were reproducible in mice. The findings challenge reported results and underscore the importance of reproducibility in psychedelic research and its potential therapeutic applications.
Life’s LEGO blocks get an upgrade
Researchers in the labs of Professor of Biochemistry, Biophysics and Structural Biology Jamie Cate & Professor of Molecular Therapeutics Alanna Schepartz engineered bacterial ribosomes to build non-canonical molecules—unlocking safer, cheaper routes to bioplastics and therapeutics.
Uncovering the hidden chemical activity of microplastics
Moisés Expósito-Alonso receives Packard Fellowship
UC Berkeley evolutionary biologist Moisés Expósito-Alonso has been awarded a prestigious Packard Fellowship for Science and Engineering, receiving nearly $1 million in unrestricted funding over 5 years. Read the full story here.
NSF backs research collaboration to sequence Antarctic genomes
The National Science Foundation (NSF) has awarded $18.4 million to a collaborative team, including UC Berkeley Integrative Biology professor Rauri Bowie as the co-principal investigator, to create an extensive genetic database of over 250 Antarctic species and 600 ecosystem samples. Read the full story here.
Tycho Mevissen on repairing life’s blueprint
Interview with Tycho Mevissen, MCB's new Assistant Professor of Biochemistry, Biophysics and Structural Biology, on his background, his lab's research, and future goals.
Digital Bat Twins – NeuroAI generates testable hypotheses about higher-level cognitive function
NATIVE-ID Seeks to Prevent Neurodegenerative Diseases by Learning the Language of Disordered Proteins
From bat flight to the most complex human movements
2026 MCB Outstanding Postdoc Awards
We are excited to announce the recipients of the 2026 MCB Outstanding Postdoc Awards! Each year, the department honors postdocs for excellence in research, leadership, and service.
Thomas Li (Bateup Lab) studies the neurodevelopmental disorder Tuberous Sclerosis Complex using stem cell derived models of brain development.
Landen Gozashti: 2026-27 Chancellor's Postdoctoral Fellow
Landen Gozashti is a 2026-27 Chancellor's Postdoctoral Fellow from Peter Sudmant's lab who studies Mobile Genetic Elements (MGEs) as well as the molecular and evolutionary mechanisms that shape evolution. Read the full story here.
Solving a longstanding problem in drug delivery
Journey to the fountain of youth: New method unravels the mysteries of rejuvenation
Research from the labs of Professors Gloria Brar and Elçin Ünal offers new insight into the mechanisms underlying gametogenic rejuvenation.
Rasmus Nielsen to receive Balzan Prize for research on molecular evolution
The International Balzan Foundation recognized Rasmus Nielsen, a professor of statistics and integrative biology at UC Berkeley, with its 2026 Balzan Prize for Molecular Evolution.
How tiny balls of human brain tissue are revealing the causes of childhood epilepsy — and possible treatments
Helen Bateup, Associate Professor of Molecular Therapeutics, and her lab are utilizing human brain organoid models to identify the underlying source of seizures in a common pediatric early-onset epilepsy, paving the way for promising treatment strategies.
Urnov receives 2026 UC Regents Innovation Gamechanger Award
Fyodor Urnov, Professor of Molecular Therapeutics, was honored with the 2026 UC Regents Innovation Gamechanger Award. The Gamechanger Award, recognizing the most impactful product brought to market, went to Urnov for pioneering custom gene therapies for children with rare diseases. By creating a new model that cuts personalized CRISPR development costs by 90%, Urnov has drastically expanded global access to these life-saving treatments. Read more about the 2026 UC Regents Innovation Awards and recipients here.
VIPR systems break the rules of the genetic code to target and twist around DNA
Researchers in the lab of Jennifer Doudna at the Innovative Genomics Institute (IGI) have identified an evolutionary precursor to the CRISPR system, solving a complex genetic puzzle through a blend of artificial intelligence and human analysis.